Inventiva SA

New Enterprise Associates and affiliated entities have reduced their beneficial ownership in Inventiva S.A. to below 5% due to an increase in the issuer's outstanding shares.

Samsara BioCapital and Opportunity Funds, along with Dr. Srinivas Akkaraju, increased their beneficial ownership in Inventiva S.A. to 7.4% following a $20 million American Depositary Share purchase.

An investor group led by Biotechnology Value Fund (BVF) has reported a decrease in its beneficial ownership of Inventiva S.A. to below 5%, primarily due to an increase in the issuer's outstanding shares.

Samsara BioCapital and its affiliates have acquired a 5.9% beneficial ownership in Inventiva S.A. through a multi-tranche private placement, with Dr. Srinivas Akkaraju joining the board.

Biotechnology Value Fund and its affiliates have significantly increased their beneficial ownership in Inventiva S.A. to 6.1% following the consummation of a multi-tranche capital raise totaling €115.6 million.

New Enterprise Associates and its affiliated investment funds have increased their beneficial ownership in Inventiva S.A. to 6.0% through a recent financing round involving the purchase of pre-funded warrants and contingent warrants.

Deep Track Capital, LP, along with its affiliates, has reported beneficial ownership of 7,800,465 ordinary shares, representing 3.76% of Inventiva S.A.'s outstanding shares as of March 31, 2026.

Eventide Asset Management and associated individuals have reduced their beneficial ownership in Inventiva S.A. to 4.6% as of December 31, 2025.

Deep Track Capital and affiliates have reported a 6.07% beneficial ownership stake in Inventiva S.A., including ordinary shares, ADSs, and warrants.

Perceptive Advisors and its affiliates have reported a 4.99% beneficial ownership stake in Inventiva S.A., including ordinary shares and various warrants.

Great Point Partners, along with Dr. Jeffrey R. Jay and Ms. Lillian Nordahl, reported a 6.06% beneficial ownership stake in Inventiva S.A. through a Schedule 13G filing.

Yiheng Capital Partners, L.P. and its affiliates have disclosed a 5.46% beneficial ownership stake in Inventiva S.A. ordinary shares.